Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

182 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma.
Hoftijzer H, Heemstra KA, Morreau H, Stokkel MP, Corssmit EP, Gelderblom H, Weijers K, Pereira AM, Huijberts M, Kapiteijn E, Romijn JA, Smit JW. Hoftijzer H, et al. Among authors: corssmit ep. Eur J Endocrinol. 2009 Dec;161(6):923-31. doi: 10.1530/EJE-09-0702. Epub 2009 Sep 22. Eur J Endocrinol. 2009. PMID: 19773371 Clinical Trial.
Sorafenib-induced hypothyroidism is associated with increased type 3 deiodination.
Abdulrahman RM, Verloop H, Hoftijzer H, Verburg E, Hovens GC, Corssmit EP, Reiners C, Gelderblom H, Pereira AM, Kapiteijn E, Romijn JA, Visser TJ, Smit JW. Abdulrahman RM, et al. Among authors: corssmit ep. J Clin Endocrinol Metab. 2010 Aug;95(8):3758-62. doi: 10.1210/jc.2009-2507. Epub 2010 May 19. J Clin Endocrinol Metab. 2010. PMID: 20484486 Clinical Trial.
Therapy of endocrine disease: response and toxicity of small-molecule tyrosine kinase inhibitors in patients with thyroid carcinoma: a systematic review and meta-analysis.
Klein Hesselink EN, Steenvoorden D, Kapiteijn E, Corssmit EP, van der Horst-Schrivers AN, Lefrandt JD, Links TP, Dekkers OM. Klein Hesselink EN, et al. Among authors: corssmit ep. Eur J Endocrinol. 2015 May;172(5):R215-25. doi: 10.1530/EJE-14-0788. Epub 2015 Jan 8. Eur J Endocrinol. 2015. PMID: 25572389 Review.
The phenotype of SDHB germline mutation carriers: a nationwide study.
Niemeijer ND, Rijken JA, Eijkelenkamp K, van der Horst-Schrivers ANA, Kerstens MN, Tops CMJ, van Berkel A, Timmers HJLM, Kunst HPM, Leemans CR, Bisschop PH, Dreijerink KMA, van Dooren MF, Bayley JP, Pereira AM, Jansen JC, Hes FJ, Hensen EF, Corssmit EPM. Niemeijer ND, et al. Eur J Endocrinol. 2017 Aug;177(2):115-125. doi: 10.1530/EJE-17-0074. Epub 2017 May 10. Eur J Endocrinol. 2017. PMID: 28490599
The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers.
Rijken JA, Niemeijer ND, Jonker MA, Eijkelenkamp K, Jansen JC, van Berkel A, Timmers HJLM, Kunst HPM, Bisschop PHLT, Kerstens MN, Dreijerink KMA, van Dooren MF, van der Horst-Schrivers ANA, Hes FJ, Leemans CR, Corssmit EPM, Hensen EF. Rijken JA, et al. Among authors: corssmit epm. Clin Genet. 2018 Jan;93(1):60-66. doi: 10.1111/cge.13055. Epub 2017 Sep 6. Clin Genet. 2018. PMID: 28503760
Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study.
Buitenwerf E, Korteweg T, Visser A, Haag CMSC, Feelders RA, Timmers HJLM, Canu L, Haak HR, Bisschop PHLT, Eekhoff EMW, Corssmit EPM, Krak NC, Rasenberg E, van den Bergh J, Stoker J, Greuter MJW, Dullaart RPF, Links TP, Kerstens MN. Buitenwerf E, et al. Among authors: corssmit epm. Eur J Endocrinol. 2018 May;178(5):431-437. doi: 10.1530/EJE-18-0006. Epub 2018 Feb 21. Eur J Endocrinol. 2018. PMID: 29467230 Free article.
182 results